Thyroid Dysfunction and Nivolumab Reponse in NSCLC

Clinical trial NCT04470440 · COMPLETED

Trial details

NCT number: NCT04470440
Sponsor: University Hospital, Brest
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Metastatic Treatment Adverse Effect Thyroid Dysfunction Immune Checkpoint Inhibitor Prognosis

Start date: 2019-10-22
Primary completion: 2019-11-05
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.